HYPERIMMUNISIERTES EIPRODUKT ZUR BEHANDLUNG ODER PRÄVENTION VON ALKOHOLISCHER LEBERERKRANKUNG UND GRAFT-VERSUS-HOST-REAKTION

European patent · EP4322973 · In force

Register entry

Publication number
EP4322973
Application number
EP22726551
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 15, 2022
Published
Feb 21, 2024
Granted
Jun 4, 2025
Protection ends at the latest
Apr 14, 2042
Next annual fee due
Apr 30, 2027
IPC classes
A61K 35/57 (2015.01)
A61K 39/00 (2006.01)
A61P 1/16 (2006.01)
A61P 37/06 (2006.01)
Priority
US 202163175603 P 16.04.2021
PCT application
PCT/US2022/024946 15.04.2022
PCT publication
WO2022/221616 20.10.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 20, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. May 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  3. Apr 16, 2026

    Change

    Published in Swissreg on 16.04.2026

  4. Jun 5, 2025

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 05.06.2025

  5. Jun 4, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Parties

Inventor

IYER, Subramanian, V.

Palm Beach, FL 33411, US

PATEL, Sunny

Stirling, NJ 07980, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.